Advertisement

Topics

Alpine Immune Sciences Presents Preclinical Data on Novel Immuno-Oncology Molecules at the Society for Immunotherapy of Cancer’s 32nd Annual Meeting

07:00 EST 10 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
-- Company’s vIgD Platform Well Positioned to Realize Next Generation Immuno-Oncology Therapeutics -- Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing treatments for autoimm...

Other Sources for this Article

Investor Relations
Pure Communications, Inc.
Courtney Dugan, 212-257-6723
cdugan@purecommunications.com
or
Media Relations
W2O Group
Jennifer Paganelli, 347-658-8290
jpaganelli@w2ogroup.com

NEXT ARTICLE

More From BioPortfolio on "Alpine Immune Sciences Presents Preclinical Data on Novel Immuno-Oncology Molecules at the Society for Immunotherapy of Cancer’s 32nd Annual Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...